Concepedia

Silke Gloaguen

SG

7

Publications

332

Citations

7

H-Index

2015

Active since

Affiliations

Marien Hospital Düsseldorf(Current)

Hôpital Saint-Louis

Groupe Francophone des Myélodysplasies

Assistance Publique – Hôpitaux de Paris

Université Paris Cité

Silke Gloaguen is an author at Marien Hospital Düsseldorf specializing in nuclear security, nuclear economics, and cancer research.

Top concepts

Publications per year

2015–2023

7

Publications

7

Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials

Uwe Platzbecker, Pierre Fenaux, Lionel Adès et al. · Blood · 2018 · 170 citations · Full text

Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network

Raphaël Itzykson, Valeria Santini, Sylvain Thépot et al. · Journal of Clinical Oncology · 2022 · 40 citations · Full text

Path-dependence, lock-in, and student perceptions of nuclear energy in France: Implications from a pilot study

Roh Pin Lee, Silke Gloaguen · Energy Research & Social Science · 2015 · 37 citations

, , +7

Decitabine Versus Hydroxyurea for Advanced Proliferative CMML: Results of the Emsco Randomized Phase 3 Dacota Trial

Raphaël Itzykson, Valeria Santini, Cendrine Chaffaut et al. · Blood · 2020 · 29 citations

Enasidenib (ENA) Is Effective in Patients with IDH2 Mutated Myelodysplastic Syndrome (MDS) : The Ideal Phase 2 Study By the GFM Group

Lionel Adès, Sophie Dimicoli‐Salazar, Marie Sébert et al. · Blood · 2021 · 22 citations

Rows per page

1–5 of 7